| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Biotech Target N V is a 10% Owner at MGNX with holdings across 3 companies. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $72.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2018 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 60,000 | $38.47 | $2,308,440.00 | +2.0% | |
| May 21, 2018 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 130,000 | $40.11 | $5,213,770.00 | +2.3% | |
| Nov 15, 2017 | 10% Owner | Buy | 60,000 | $7.57 | $453,966.00 | +2.7% |